Group One Trading’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-485
| Closed | -$3.74K | – | 8199 |
|
|
2025
Q1 | $3.74K | Buy |
+485
| New | +$5.32K | ﹤0.01% | 6767 |
|
|
2023
Q4 | – | Sell |
-3,119
| Closed | -$44.2K | – | 7691 |
|
|
2023
Q3 | $22.6K | Sell |
3,119
-140
| -4% | -$937 | ﹤0.01% | 5798 |
|
|
2023
Q2 | $17.2K | Sell |
3,259
-1,061
| -25% | -$3.8K | ﹤0.01% | 6080 |
|
|
2023
Q1 | $13.4K | Buy |
4,320
+1,231
| +40% | +$4.68K | ﹤0.01% | 5775 |
|
|
2022
Q4 | $12.2K | Sell |
3,089
-3,386
| -52% | -$13.8K | ﹤0.01% | 5921 |
|
|
2022
Q3 | $24K | Buy |
+6,475
| New | +$82.2K | ﹤0.01% | 5941 |
|
|
2021
Q3 | – | Sell |
-868
| Closed | -$28.6K | – | 8405 |
|
|
2021
Q2 | $28K | Buy |
+868
| New | +$29.8K | ﹤0.01% | 6993 |
|
|
2020
Q4 | – | Sell |
-5
| Closed | -$217 | – | 6693 |
|
|
2020
Q3 | $0 | Sell |
5
-1,244
| -100% | -$48.7K | ﹤0.01% | 6275 |
|
|
2020
Q2 | $55K | Buy |
1,249
+303
| +32% | +$14.2K | ﹤0.01% | 4288 |
|
|
2020
Q1 | $31K | Buy |
946
+826
| +688% | +$38K | ﹤0.01% | 4004 |
|
|
2019
Q4 | $6K | Buy |
120
+27
| +29% | +$1.13K | ﹤0.01% | 4714 |
|
|
2019
Q3 | $3K | Buy |
+93
| New | +$5.01K | ﹤0.01% | 4859 |
|
|
2018
Q4 | – | Sell |
-113
| Closed | -$8.33K | – | 5070 |
|
|
2018
Q3 | $9K | Buy |
+113
| New | +$8.95K | ﹤0.01% | 4681 |
|
|
2018
Q2 | – | Sell |
-162
| Closed | -$28.4K | – | 5250 |
|
|
2018
Q1 | $31K | Buy |
162
+161
| +16,100% | +$30K | ﹤0.01% | 3891 |
|
|
2017
Q4 | $0 | Buy |
+1
| New | +$51 | ﹤0.01% | 4981 |
|
|
2017
Q3 | – | Sell |
-61
| Closed | -$2K | – | 4944 |
|
|
2017
Q2 | $2K | Buy |
+61
| New | +$2.19K | ﹤0.01% | 4564 |
|
|
2016
Q3 | – | Sell |
-24
| Closed | -$4K | – | 4676 |
|
|
2016
Q2 | $4K | Buy |
+24
| New | +$4.09K | ﹤0.01% | 4318 |
|
|
2015
Q1 | – | Sell |
-2
| Closed | -$4.13K | – | 4930 |
|
|
2014
Q4 | $4K | Sell |
2
-56
| -97% | -$108K | ﹤0.01% | 4539 |
|
|
2014
Q3 | $115K | Sell |
58
-11
| -16% | -$27.2K | ﹤0.01% | 2863 |
|
|
2014
Q2 | $247K | Buy |
69
+36
| +109% | +$117K | ﹤0.01% | 2213 |
|
|
2014
Q1 | $123K | Sell |
33
-41
| -55% | -$152K | ﹤0.01% | 2883 |
|
|
2013
Q4 | $243K | Buy |
74
+56
| +311% | +$221K | ﹤0.01% | 2261 |
|
|
2013
Q3 | $76K | Sell |
18
-34
| -65% | -$137K | ﹤0.01% | 3247 |
|
|
2013
Q2 | $176K | Buy |
+52
| New | +$198K | ﹤0.01% | 2300 |
|
Other funds holding GYRE
SS
Group One Trading's GYRE Position: Q2 2025 in Review
Group One Trading sold out of Gyre Therapeutics (GYRE) in Q2 2025, closing a stake of 485 shares — an estimated $3.74K sold.
Group One Trading first reported a position in GYRE in Q2 2013 and held it in 24 quarters. The position peaked at $247K in Q2 2014. 48 funds tracked by Wall St. Rank hold GYRE as of Q2 2025.
- Group One Trading reported no remaining Gyre Therapeutics position as of Q2 2025 after selling out during the quarter.
- Group One Trading sold 485 Gyre Therapeutics shares in Q2 2025, an estimated $3.74K.
- Group One Trading first reported a position in Gyre Therapeutics in Q2 2013 and held it in 24 quarters.
- Group One Trading's Gyre Therapeutics position peaked at $247K in Q2 2014.
- 48 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2025.
Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.